1189483-12-2

1189483-12-2 structure
1189483-12-2 structure
  • Name: Terpinen-4-ol-d7
  • Chemical Name: Terpinen-4-ol-d7
  • CAS Number: 1189483-12-2
  • Molecular Formula: C10H11D7O
  • Molecular Weight: 161.29
  • Catalog: Research Areas Cancer
  • Create Date: 2021-11-08 19:58:14
  • Modify Date: 2024-01-17 11:35:57
  • Terpinen-4-ol-d7 (4-Carvomenthenol-d7) is the deuterium labeled Terpinen-4-ol. Terpinen-4-ol (4-Carvomenthenol), a naturally occurring monoterpene, is the main bioactive component of tea-tree oil. Terpinen-4-ol suppresses inflammatory mediator production by activated human monocytes. Terpinen-4-ol significantly enhances the effect of several chemotherapeutic and biological agents[1][2][3].

Name Terpinen-4-ol-d7
Description Terpinen-4-ol-d7 (4-Carvomenthenol-d7) is the deuterium labeled Terpinen-4-ol. Terpinen-4-ol (4-Carvomenthenol), a naturally occurring monoterpene, is the main bioactive component of tea-tree oil. Terpinen-4-ol suppresses inflammatory mediator production by activated human monocytes. Terpinen-4-ol significantly enhances the effect of several chemotherapeutic and biological agents[1][2][3].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Hart PH, et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000 Nov;49(11):619-26.

[3]. Shapira S, et al. Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers. PLoS One. 2016 Jun 8;11(6):e0156540.

Molecular Formula C10H11D7O
Molecular Weight 161.29